SCM
TMO icon

SCS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

SCS Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$859K Sell
1,711
-242
-12% -$116K 0.01% 308
2026
Q1 		$961K Sell
1,953
-186
-9% -$101K 0.01% 279
2025
Q4 		$1.24M Buy
2,139
+85
+4% +$48.1K 0.01% 261
2025
Q3 		$997K Sell
2,054
-117
-5% -$54.5K 0.01% 286
2025
Q2 		$881K Sell
2,171
-528
-20% -$221K 0.01% 307
2025
Q1 		$1.34M Buy
+2,699
New +$1.46M 0.02% 234

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SCS Capital Management's TMO Position: Q2 2026 in Review

SCS Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $116K and leaving 1,711 shares worth $859K. The position accounts for 0.01% of the portfolio, ranked #308.

SCS Capital Management first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.34M in Q1 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SCS Capital Management held 1,711 shares of Thermo Fisher Scientific worth $859K as of Q2 2026.
  • SCS Capital Management sold 242 Thermo Fisher Scientific shares in Q2 2026, an estimated $116K.
  • Thermo Fisher Scientific made up 0.01% of SCS Capital Management's portfolio in Q2 2026, its #308 holding.
  • SCS Capital Management first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's Thermo Fisher Scientific position peaked at $1.34M in Q1 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.